Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024
NEWARK, CA / ACCESSWIRE / July 22, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that...
Pharmaceutical
HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200
Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany...
Rapid Dose Announces Closing of First Tranche of Common Share Private Placement
Burlington, Ontario--(Newsfile Corp. - July 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") is pleased...
Navigating the Radiological Landscape: Insights into Radiotherapy and Nuclear Medicine Markets
Advancements in AI (Artificial Intelligence) technology is poised to revolutionize radiotherapy, enhancing patient outcomes, and streamlining clinical workflows. Meanwhile, the...
Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia
PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / July 22, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the...
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS
BEIJING, July 19, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and...
Wearable Technology Market Transforms Home Healthcare with Continuous Health Monitoring Devices, Finds Maximize Market Research
PUNE, India, July 19, 2024 /PRNewswire/ -- Wearable Technology Market size is expected to grow from US$ 59.87 Bn. in 2023...
Printed and Flexible Sensors Market Sees Increased Opportunities with Rising Smartwatch Shipments and Health Tracking Needs, Finds Maximize Market Research
PUNE, India, July 19, 2024 /PRNewswire/ -- Printed & Flexible Sensors Market size was valued at US$ 11.65 Bn. in...
Antheia Announces New Funding to Support Domestic Production of Critical Pharmaceutical Ingredients
Company awarded government project agreement to onshore key pharmaceutical supply chains, alongside strategic investment from In-Q-Tel and Echo MENLO PARK,...
Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule
CHICAGO, IL / ACCESSWIRE / July 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
Bausch Health Welcomes Two New Members to the Executive Leadership Team
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two...
Join Nutriband’s Exclusive Live Investor Webinar and Q&A Session on July 25
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a developer of transdermal pharmaceutical solutions, is pleased...
Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement
July 19, 2024 Biodexa Pharmaceuticals PLC Announces Pricing of $5.0 Million Registered Direct Offering and Concurrent Private Placement Biodexa Pharmaceuticals...
Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated...
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
The Tafenoquine for Babesiosis clinical trial will be conducted at three sites: Yale University, Rhode Island Hospital and Tufts Medical...
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
SARASOTA, FL, July 19, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage...
Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule
SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing...
SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®
Exercise of Procurement Option under Current Contract Reflects Continuing Action to Enhance Orthopoxvirus PreparednessNEW YORK, July 19, 2024 (GLOBE NEWSWIRE)...
Clearmind Medicine Signs an Agreement to Source Manufacturers and Distributors for its Alcohol Substitute Beverage Product
Vancouver, Canada, July 19, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a...
Appili Therapeutics Announces Second Amendment to Arrangement Agreement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, July 18,...